Inés Lecoq

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

M. Chapellier, M. Andersen, M. Zocca, 2022, Oncoimmunology.

TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer

L. Grøntved, M. Donia, D. H. Madsen, 2022, Journal for ImmunoTherapy of Cancer.

Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

A. Mondal, Lauren M F Merlo, Souvik Dey, 2020, Journal for ImmunoTherapy of Cancer.